Skip to content

Home
Artificial intelligence
Biotechnology
Genetics
Medical Technology

Home
Uncategorized
Praxis rises on ulixacaltamide gaining Breakthrough Therapy status

Praxis rises on ulixacaltamide gaining Breakthrough Therapy status

Dec 29, 2025

Post navigation

Ultragenyx plummets as late-stage studies of asset for genetic bone disorder fails

Biggest stock movers Monday: DigitalBridge, Ultragenyx Pharmaceutical

PR Newswire
GlobeNewswire

Contact
Privacy Policy

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Search for: